Gamida Cell (GMDA) Stock Forecast & Price Target

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Short Interest Trends

Gamida Cell - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 4 Analyst Ratings

Based on 4 Wall Street analysts who have issued ratings for Gamida Cell in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 4 analysts, 1 has given a hold rating, and 3 have given a buy rating for GMDA.

Consensus Price Target

$4.75

High Forecast	$6.00
Average Forecast	$4.75
Low Forecast	$2.00

According to the 4 analysts' twelve-month price targets for Gamida Cell, the average price target is $4.75. The highest price target for GMDA is $6.00, while the lowest price target for GMDA is $2.00. .

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$4.75	$4.75	$4.75	$7.60
Forecasted Upside	N/A	951.28% Upside	951.28% Upside	417.79% Upside

Get Gamida Cell Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for GMDA and its competitors with MarketBeat's FREE daily newsletter.

Ad DTI

Heard about the 72-Hour Profit Surge? Read this…

One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…

Click here now to get all the details.

GMDA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GMDA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Gamida Cell Stock vs. The Competition

Type	Gamida Cell	Medical Companies	S&P 500
Consensus Rating Score	2.75	2.72	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside		3,121.51% Upside	9.09% Upside
News Sentiment Rating	Neutral News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
1/29/2024	JMP Securities 2 of 5 stars	Reiterated Rating	Market Outperform ➝ Market Perform
12/5/2023	Needham & Company LLC 3 of 5 stars	Reiterated Rating	Buy ➝ Buy	$6.00	+1,698.51%
11/15/2023	Piper Sandler 2 of 5 stars	Lower Target	Overweight ➝ Overweight	$5.00 ➝ $2.00	+419.07%
11/15/2023	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$11.00 ➝ $5.00	+1,251.32%
3/27/2023	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform	$10.00 ➝ $8.00	+1,076.45%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:56 AM ET.

GMDA Forecast - Frequently Asked Questions

What is Gamida Cell's forecast for 2024?: According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Gamida Cell is $4.75, with a high forecast of $6.00 and a low forecast of $2.00.
Should I buy or sell Gamida Cell stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Gamida Cell in the last year. There is currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" GMDA shares.
Does Gamida Cell's stock price have much upside?: According to analysts, Gamida Cell's stock has a predicted upside of 951.28% based on their 12-month stock forecasts.
Do Wall Street analysts like Gamida Cell more than its competitors?: Analysts like Gamida Cell more than other "medical" companies. The consensus rating score for Gamida Cell is 2.75 while the average consensus rating score for "medical" companies is 2.72. Learn more on how GMDA compares to other companies.